Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Diagnosis of Invasive Aspergillosis in a High Risk Group of Patients Using Serum and Bronchoalveolar Lavage Fluid Real Time PCR and Galactomannan ELISA

NCT00462657 is registered in ClinicalTrials.gov with St. Bartholomew's Hospital as lead sponsor.

NCT NCT00462657
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462657 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Diagnosis of Invasive Aspergillosis in a High Risk Group of Patients Using Serum and Bronchoalveolar Lavage Fluid Real Time PCR and Galactomannan ELISA
Lead sponsor
St. Bartholomew's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2005
Completion date
Not reported
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease, infection, leukemia, myelodysplastic syndromes, myelodysplastic/myeloproliferative neoplasms